Connecticut House passed Tuesday a bipartisan bill to regulate the cannabis and hemp industries in a 130-16 vote, sending it to...
Yesterday, the Department of Justice affirmed that the DEA has concurred with an HHS recommendation to move cannabis from Schedule...
With the race to the White House heating up — and election polls showing President Joe Biden and twice-impeached former...
Rumors of an imminent drug policy announcement swept through the industry Tuesday morning after the Associated Press reported the Drug Enforcement Administration...
This article was originally published in The Fresh Toast and appears here with permission. CBD has been shown to promote...
This article was originally published on Leafly.com and appears here with permission. A recent observational study conducted by a team of UK-based...
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 86.36% at $0.04 Pharmadrug (OTC:LMLLF) shares closed up 18.72% at $0.02 Maple...
At the recent Benzinga Cannabis Capital Conference in Florida, a panel featuring industry experts David Mukpo, CEO of Pamos Beverage,...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly...
The Biden administration's plan to reclassify cannabis as a Schedule III substance through the Drug Enforcement Administration (DEA) could have...